Jennifer C. Goldsack co-founded and serves as the Chief Executive Officer of the Digital Medicine Society (DiMe), a 501(c)(3) non-profit organization dedicated to advancing digital medicine to optimize human health. Ms Goldsack’s research focuses on applied approaches to the safe, effective, and equitable use of digital technologies to improve health, healthcare, and health research. She is a member of the Roundtable on Genomics and Precision Health at the National Academies of Science, Engineering and Medicine.
Previously, Ms Goldsack spent several years at the Clinical Trials Transformation Initiative (CTTI), a public-private partnership co-founded by Duke University and the FDA. There, she led development and implementation of several projects within CTTI’s Digital Program and was the operational co-lead on the first randomized clinical trial using FDA’s Sentinel System.
Ms Goldsack spent five years working in research at the Hospital of the University of Pennsylvania, first in Outcomes Research in the Department of Surgery and later in the Department of Medicine. More recently, she helped launch the Value Institute, a pragmatic research and innovation center embedded in a large academic medical center in Delaware.
Ms Goldsack earned her master’s degree in chemistry from the University of Oxford, England, her masters in the history and sociology of medicine from the University of Pennsylvania, and her MBA from the George Washington University. Additionally, she is a certified Lean Six Sigma Green Belt and a Certified Professional in Healthcare Quality. Ms Goldsack is a retired athlete, formerly a Pan American Games Champion, Olympian, and World Championship silver medalist.
Saturday Morning 4th Feb Conference
Empowering Health: Harnessing AI’s Disruptive Benefit in Healthcare
AI is everywhere, and we are impacted by its capabilities in work and life every day. We already see the massive contributions it is making across healthcare domains, but are we prepared to leverage this tremendous value? Dr. Edmondo Robinson of Moffitt Cancer Research sits down with experts in all things healthcare and AI to discuss the disruptive ways we can capture its benefits to empower a healthier future.